COMBINATION THERAPIES FOR TREATMENT OF BCMA-RELATED CANCERS AND AUTOIMMUNE DISORDERS Application EP-4269594-A3 European Patent Office 20 Dec 2023
HEAD AND NECK CANCER COMBINATION THERAPY COMPRISING AN IL-2 CONJUGATE AND PEMBROLIZUMAB Application WO-2023122573-A1 World Intellectual Property Organisation (WIPO) 29 Jun 2023
HEAD AND NECK CANCER COMBINATION THERAPY COMPRISING AN IL-2 CONJUGATE AND PEMBROLIZUMAB Application WO-2022256534-A1 World Intellectual Property Organisation (WIPO) 08 Dec 2022